Intra-Cellular Therapies Inc. Common Stock (ITCI) Real-time Stock Quotes - Nasdaq offers real-time quotes & market activity data for US and global markets. The share price of Intra-Cellular Therapies ( NASDAQ: ITCI) - the New York based central nervous system focused biotech - is up by 450% across a five-year period, and >50% over a 12-month period ...Real-time Price Updates for Intra-Cellular Ther (ITCI-Q), along with buy or sell indicators, analysis, charts, historical performance, news and moreWe take a look at earnings estimates for some clues. ITCI 62.85 (+0.02%) 65.36 (-2.49%) Intra-Cellular Therapeutics (ITCI) announces positive top-line data from its phase III study evaluating lumateperone for the treatment of depression. Stock surges 16% following the news. ITCI. 48.33M. MSFT. 404.06. -0.61%. 21.64M. View today's Intracellular Th stock price and latest ITCI news and analysis. Create real-time notifications to follow any changes in the live stock price.The No. 2 U.S. automaker's lowest-price 2023 model year Mach E version now has a suggested retail price of $39,895, down from $42,995. Other versions including the extended-range premium version ...0.98%. $141.28B. ESCO Technologies Inc. 1.42%. $2.64B. ITRI | Complete Itron Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.In another report released on February 23, Needham also reiterated a Buy rating on the stock with a $82.00 price target. ITCI’s price has also changed moderately …Intra-Cellular Therapies (NASDAQ:ITCI) is scheduled to announce Q4 earnings results on Thursday, February 22nd, before market open.The consensus EPS Estimate is -$0.46 and the consensus Revenue ...ITCI: Intra-Cellular Therapies Inc Stock Price Quote - NASDAQ GS - Bloomberg Bloomberg Connecting decision makers to a dynamic network of information, people and ideas, …Intra-Cellular Therapies Inc CEO Sharon Mates Sells 191,362 Shares. Sharon Mates, the Chairman, President & CEO of Intra-Cellular Therapies Inc (NASDAQ:ITCI), has sold …IntraCellular Therapies (ITCI) Quote Overview » More Research » IntraCellular Therapies (ITCI) Full Company Report Better trading starts here. Company Summary11-Feb-2024 ... ITCI: Intra-Cellular Therapies Inc. - stock prices historical data. No views · 8 minutes ago ...more. datacharm. 31. Subscribe.ITCI stock quote, chart and news. Get ITCI's stock price today.November 2, 2023 · 2 min read. Intra-Cellular Therapies Inc ( NASDAQ:ITCI) reported Q3 2023 total revenues of $126.2 million, a significant increase from $71.9 million in Q3 2022. Net product ...The Zacks database contains over 10,000 stocks. All of those stocks are classified into three groups: Sector, M Industry and X Industry. There are 17 Sectors, 60 different M Industries, and 265 X ...The 15 analysts offering 1 year price forecasts for ITCI have a max estimate of — and a min estimate of —. Analyst rating Based on 15 analysts giving stock ratings to ITCI in the past 3 months.ITCI Earnings Date and Information. Intra-Cellular Therapies has confirmed that its next quarterly earnings report will be published on Thursday, February 22nd, 2024. Intra-Cellular Therapies will be holding an earnings conference call on Thursday, February 22nd at 8:30 AM Eastern. Interested parties can register for or listen to the call..Penny stocks may sound like an interesting investment option, but there are some things that you should consider before deciding whether this is the right investment choice for you...Full year 2023 total revenues of $464.4 million, compared to $250.3 million in 2022 Full year 2023 CAPLYTA net product sales were $462.2 million, representing year-over-year growth of 86%. CAPLYTA fourth quarter 2023 net product sales grew to $131.5 million, a 50% increase over the same period in 2022 In 2023, CAPLYTA total prescriptions ... Full year 2023 total revenues of $464.4 million, compared to $250.3 million in 2022 Full year 2023 CAPLYTA net product sales were $462.2 million, representing year-over-year growth of 86%. CAPLYTA fourth quarter 2023 net product sales grew to $131.5 million, a 50% increase over the same period in 2022 In 2023, CAPLYTA total prescriptions ... Feb 16, 2024 · See the latest Intra-Cellular Therapies Inc stock price (ITCI:XNAS), related news, valuation, dividends and more to help you make your investing decisions. Historical daily share price chart and data for Intra-Cellular Therapies since 2014 adjusted for splits and dividends. The latest closing stock price for Intra-Cellular Therapies as of February 07, 2024 is 68.57.. The all-time high Intra-Cellular Therapies stock closing price was 73.65 on December 27, 2023.; The Intra-Cellular Therapies 52-week high stock …Over the past 17 months, ITCI's average price target has gone up $10.17. Over the past 47 weeks, ITCI's average upside potential has been 33.5%. Date Number of Analysts ... In terms of how INTRA-CELLULAR THERAPIES INC fares relative to Pharmaceutical Products stocks, note that its average analyst price target is higher than 4398.47% of that group.(+0.18%) Intra-Cellular Therapies, Inc. (ITCI) NasdaqGS - NasdaqGS Real Time Price. Currency in USD Follow 2W 10W 9M 73.28 -0.42 (-0.57%) At close: 04:00PM EST 74.25 …Price Target. Based on short-term price targets offered by 15 analysts, the average price target for Intra-Cellular Therapies comes to $79.60. The forecasts range from a low of $59.00 to a high of ...Neumann Mark filed to sell 36,604 shares at $66.7. February 5 '24. Similar companies. Company, Price, AI Score ...Investing in the stock market takes a lot of courage, a lot of research, and a lot of wisdom. One of the most important steps is understanding how a stock has performed in the past...If you want to keep up to date on the stock market you have a device in your pocket that makes that possible. Your phone can track everything finance-related and help keep you up t...Intra-Cellular Therapies (ITCI) has the following price history information. Looking back at ITCI historical stock prices for the last five trading days, on February 13, 2024, ITCI opened at $70.80, traded as high as $71.28 and as low as $69.35, and closed at $70.40. Trading volume was a total of 858.70K shares. Find the latest Viking Therapeutics, Inc. (VKTX) stock quote, history, news and other vital information to help you with your stock trading and investing.TradingView India. View live Intra-Cellular Therapies Inc. chart to track its stock's price action. Find market predictions, ITCI financials and market news.TipRanks.com is a website that provides stock market research, news and analyst forecasts for various stocks. If you are interested in itci, you can find its latest price, rating, news, earnings and more on this page. You can also compare itci with other stocks in the same sector and see what the top analysts think about it. TipRanks.com helps you make …ITCI. Intra-Cellular Therapies, Inc. 75.65. +0.76. +1.01%. Here we present three biotech stocks, CRSP, ITCI and DVAX, which most analysts on Wall Street are optimistic about. These companies have ...The latest price target for . Intra-Cellular Therapies (NASDAQ: ITCI) was reported by RBC Capital on January 31, 2024.The analyst firm set a price target for $86.00 expecting ITCI to rise to ... 48.33M. MSFT. 404.06. -0.61%. 21.64M. View today's Intracellular Th stock price and latest ITCI news and analysis. Create real-time notifications to follow any changes in the live stock price.ITCI, Intra-Cellular Therapies - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines Get Options quotes for Intra-Cellular Therapies, Inc. (ITCI). Calls and Puts. Strike price, bid, ask, volume, open interest. In the money.52 Week High. $76.11. 52 Week Low. $42.01. Data Provided by Refinitiv. Minimum 15 minutes delayed. The Investor Relations website contains information about Intra-Cellular Therapies Inc.'s business for stockholders, potential investors, and financial analysts.Is Intra-Cellular Therapies (NASDAQ:ITCI) the best stock in the Pharmaceutical preparations industry? Compare top ITCI competitors at MarketBeat. Skip to main content. S&P 500 5,005.57 (-0.48%) DOW 38,627.99 (-0.37%) ... Occidental Petroleum stock price is ready to gush higher; S&P 500's surge to new highs: Bull trap …The latest price target for Intra-Cellular Therapies ( NASDAQ: ITCI) was reported by Goldman Sachs on Thursday, January 18, 2024. The analyst firm set a price target for 64.00 expecting ITCI to ...11-Feb-2024 ... ITCI: Intra-Cellular Therapies Inc. - stock prices historical data. No views · 8 minutes ago ...more. datacharm. 31. Subscribe.Based on 9 Wall Street analysts offering 12 month price targets for Intra-Cellular Therapies in the last 3 months. The average price target is $82.38 with a high forecast of $100.00 and a low forecast of $75.00. The average price target represents a 14.43% change from the last price of $71.99. Feb 15, 2024 · A high-level overview of Intra-Cellular Therapies, Inc. (ITCI) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Intra-Cellular Therapies Inc. 430 East 29th Street. Suite 900. New York, New York 10016. Phone 1 464 440-9333. Industry Pharmaceuticals. Sector Health Care/Life Sciences. Fiscal Year-end 12/2023 ...Is Intra-Cellular Therapies (NASDAQ:ITCI) the best stock in the Pharmaceutical preparations industry? Compare top ITCI competitors at MarketBeat. Skip to main content. S&P 500 5,005.57 (-0.48%) DOW 38,627.99 (-0.37%) ... Occidental Petroleum stock price is ready to gush higher; S&P 500's surge to new highs: Bull trap …Penny stocks may sound like an interesting investment option, but there are some things that you should consider before deciding whether this is the right investment choice for you...On February 16, 2024, ITCI’s average trading volume was 844.11K shares. ITCI) stock’s latest price update. Intra-Cellular Therapies Inc (NASDAQ: ITCI) has seen a rise in its stock price by 4.03 in relation to its previous close of 71.99. However, the company has experienced a 4.59% gain in its stock price over the last five trading sessions.Stock control is important because it prevents retailers from running out of products, according to the Houston Chronicle. Stock control also helps retailers keep track of goods th...by Zacks Equity Research Published on November 23,2023. The mean of analysts' price targets for Intra-Cellular (ITCI) points to a 33% upside in the stock. While this highly sought-after metric has ...ITCI - Intra-Cellular Therapies Inc - Stock screener for investors and traders, financial visualizations. Intra-Cellular Therapies (NASDAQ:ITCI) is scheduled to announce Q4 earnings results on Thursday, February 22nd, before market open.The consensus EPS Estimate is -$0.46 and the consensus Revenue ...Intra-Cellular reported positive results from study 403 in MDD patients with mixed features and bipolar disorder patients with mixed features. See why I'm bullish on ITCI stock.Jan 23, 2024 · Get Intra-Cellular Therapies Inc (ITCI.O) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments ITCI Earnings Date and Information. Intra-Cellular Therapies has confirmed that its next quarterly earnings report will be published on Thursday, February 22nd, 2024. …The Intra-Cellular Therapies, Inc. stock price is closed at $ 66.69 with a total market cap valuation of $ 6.42B ( 96.24M shares outstanding). The Intra-Cellular Therapies, Inc. is trading on NASDAQ with the sign ITCI. Intra-Cellular Therapies, Inc. …Neumann Mark filed to sell 36,604 shares at $66.7. February 5 '24. Similar companies. Company, Price, AI Score ...Jan 29, 2024 · Nov. 08. CI. RBC Trims Price Target on Intra-Cellular Therapies to $76 From $77, Keeps Outperform Rating. Nov. 03. MT. Earnings Flash (ITCI) INTRA-CELLULAR THERAPIES Reports Q3 Revenue $126.2M. Nov. 02. MT. Transcript : Intra-Cellular Therapies, Inc., Q3 2023 Earnings Call, Nov 02, 2023. Stocks trading online may seem like a great way to make money, but if you want to walk away with a profit rather than a big loss, you’ll want to take your time and learn the ins an...Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report. Intra-Cellular Therapies Inc. (ITCI) : Free Stock Analysis Report. To read this article on Zacks.com ...If you need cash, aren’t happy with your investment returns or want to diversify your investments, you may have to liquidate some of your stocks. Buying and selling stocks is extre...Nuvama Wealth Management maintained its buy call on the ITC stock with a target price of ₹ 560, implying a 24 per cent upside from the stock's Thursday's (October 19) closing of ₹ 450.30 on ...On today's stock market, ITCI stock surged 16.4% to close at 55.73. That put shares above their 200-day moving average , according to MarketSmith.com . ITCI Stock: Patients With 'Mixed Features'Intra-Cellular Therapies Inc (ITCI) current stock price is $67.25 with a 24-hour trading volume of 549.44K. The stock decreased by -1.38% in the last 24 hours and declined by -4.60% in the past month. ITCI chart suggests a potential bearish trend as ITCI stock price is below the pivot point level of $68.08, if it continues to fall close to the support level of …Intra-Cellular Therapies (ITCI) Stock Price Performance. Intra-Cellular Therapies (ITCI) Stock Key Data ... Consensus Price Target is the stock price analysts expect to see within a period of 0-18 ... Intra-Cellular Therapeutics (ITCI) announces positive top-line data from its phase III study evaluating lumateperone for the treatment of depression. Stock surges 16% following the news.Find the latest Financials data for Intra-Cellular Therapies Inc. Common Stock (ITCI) at Nasdaq.com.Intra-Cellular Therapies (NASDAQ:ITCI) is scheduled to announce Q4 earnings results on Thursday, February 22nd, before market open.The consensus EPS Estimate is -$0.46 and the consensus Revenue ...IntraCellular Therapies - ITCI - Stock Price Today - Zacks IntraCellular Therapies (ITCI) (Delayed Data from NSDQ) $74.89 USD +2.90 (4.03%) Updated Feb …In another report released on February 23, Needham also reiterated a Buy rating on the stock with a $82.00 price target. ITCI’s price has also changed moderately …Feb 16, 2024 · According to 11 analysts, the average rating for ITCI stock is "Strong Buy." The 12-month stock price forecast is $81.55, which is an increase of 16.23% from the latest price. In another report released on February 23, Needham also reiterated a Buy rating on the stock with a $82.00 price target. See today’s best-performing stocks on …The share price of Intra-Cellular Therapies ( NASDAQ: ITCI) - the New York based central nervous system focused biotech - is up by 450% across a five-year period, and >50% over a 12-month period ...Intra-Cellular Therapies Stock Earnings. The value each ITCI share was expected to gain vs. the value that each ITCI share actually gained. Intra-Cellular Therapies ( ITCI) reported Q3 2023 earnings per share (EPS) of -$0.25, beating estimates of -$0.57 by 55.38%. In the same quarter last year, Intra-Cellular Therapies 's earnings per share ... 48.33M. MSFT. 404.06. -0.61%. 21.64M. View today's Intracellular Th stock price and latest ITCI news and analysis. Create real-time notifications to follow any changes in the live stock price.View, at a glance, the 52-Week High and Low for a symbol, along with the 61.8%, 50%, and 38.2% Fibonacci levels. These figures correspond to the information presents on the Trader's Cheat Sheet page. The historical data and Price History for Intra-Cellular Ther (ITCI) with Intraday, Daily, Weekly, Monthly, and Quarterly data available for download.View Intra-Cellular Therapies, Inc. ITCI stock quote prices, financial information, real-time forecasts, and company news from CNN. Options Prices. Barchart allows you to view options by Expiration Date (select the expiration month/year using the drop-down menu at the top of the page). Weekly expiration dates are labeled with a (w) in the expiration date list. Options information is delayed a minimum of 15 minutes, and is updated at least once every 15-minutes through-out ...See the latest Intra-Cellular Therapies Inc stock price (ITCI:XNAS), related news, valuation, dividends and more to help you make your investing decisions.4 days ago · 0.74%. $66.7M. ITCI | Complete Intra-Cellular Therapies Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. View, at a glance, the 52-Week High and Low for a symbol, along with the 61.8%, 50%, and 38.2% Fibonacci levels. These figures correspond to the information presents on the Trader's Cheat Sheet page. The historical data and Price History for Intra-Cellular Ther (ITCI) with Intraday, Daily, Weekly, Monthly, and Quarterly data available for download.$42.01 - $76.11 Get the latest Intra-Cellular Therapies Inc (ITCI) real-time quote, historical performance, charts, and other financial information to help you make more informed …Intra-Cellular Therapies Inc CEO Sharon Mates Sells 191,362 Shares. Sharon Mates, the Chairman, President & CEO of Intra-Cellular Therapies Inc (NASDAQ:ITCI), has sold …ITCI Stock Summary. The ratio of debt to operating expenses for INTRA-CELLULAR THERAPIES INC is higher than it is for about just 7.52% of US stocks. ITCI's price/sales ratio is 15.91; that's higher than the P/S ratio of 93% of US stocks. As for revenue growth, note that ITCI's revenue has grown 123.34% over the past 12 months; that beats the ...The Zacks database contains over 10,000 stocks. All of those stocks are classified into three groups: Sector, M Industry and X Industry. There are 17 Sectors, 60 different M Industries, and 265 X ...
Doucefleur/iStock via Getty Images. At a Glance. Intra-Cellular Therapies (NASDAQ:ITCI) presents a compelling narrative that intertwines robust financial growth with significant clinical potential .... Ohio power tool
Find the latest Iteris, Inc. (ITI) stock quote, history, news and other vital information to help you with your stock trading and investing. In another report released on February 23, Needham also reiterated a Buy rating on the stock with a $82.00 price target. See today’s best-performing stocks on TipRanks >>ITI : 4.82 (-1.23%) RDCM : 9.52 (+4.33%) 3 Tech Stocks to Secure Before the End of the Year stocknews.com - Tue Dec 19, 2023. The technology industry is booming due to growing demand for tech products and services amid rapid digitalization among enterprises in different sectors.ITC Share Price: Find the latest news on ITC Stock Price. Get all the information on ITC with historic price charts for NSE / BSE. Experts & Broker view also get the ITC Ltd. buy/sell tips ...30-Jan-2014 ... (OTCQB: ITCI), a biopharmaceutical company focused on the development of therapeutics for CNS disorders, today announced the pricing of an ...Intra-Cellular Therapies (ITCI) Stock Price Performance. Intra-Cellular Therapies (ITCI) Stock Key Data ... Consensus Price Target is the stock price analysts expect to see within a period of 0-18 ... Feb 16, 2024 · See the latest Intra-Cellular Therapies Inc stock price (ITCI:XNAS), related news, valuation, dividends and more to help you make your investing decisions. Feb 15, 2024 · A high-level overview of Intra-Cellular Therapies, Inc. (ITCI) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. ROIV Options Chain. Options Chain Tools: Short Interest Tracker. Short Interest Increases. Short Interest Decreases. Unusual Call Volume. Unusual Put Volume. This page (NASDAQ:ITCI) was last updated on 2/22/2024 by MarketBeat.com Staff. Get 30 Days of MarketBeat All Access Free.Find the latest Infinite Group, Inc. (IMCI) stock quote, history, news and other vital information to help you with your stock trading and investing.4.07 M Change from Last 15.97% Percent of Float 4.34% Research & Ratings Intra-Cellular Therapies Inc. Per-Share Earnings, Actuals and Estimates Actual Analyst Range …In another report released on February 23, Needham also reiterated a Buy rating on the stock with a $82.00 price target. See today’s best-performing stocks on …Full year 2023 total revenues of $464.4 million, compared to $250.3 million in 2022 Full year 2023 CAPLYTA net product sales were $462.2 million, representing year-over-year growth of 86%. CAPLYTA fourth quarter 2023 net product sales grew to $131.5 million, a 50% increase over the same period in 2022 In 2023, CAPLYTA total prescriptions ... Mar 28, 2023 · 04:20 PM ET 03/28/2023. Intra-Cellular Therapies ( ITCI) said Tuesday that its depression treatment succeeded in a key study, and ITCI stock broke definitively above its 200-day line for the first ... Here's why making dividend investing a primary strategy as you build your retirement portfolio may not be the best decision. Is building a dividend portfolio a good idea, and what ...Find the latest Iteris, Inc. (ITI) stock quote, history, news and other vital information to help you with your stock trading and investing. Since its IPO on the Shenzhen stock exchange, its share price has gone up every day by the exact same amount. Baofeng Technologies is China’s best performing stock this year. Since...Find the latest Iteris, Inc. (ITI) stock quote, history, news and other vital information to help you with your stock trading and investing. You can buy or sell ITCI and other ETFs, options, and stocks. View the real-time ITCI price chart on Robinhood and decide if you want to buy or sell commission-free. Other fees such as trading (non-commission) fees, Gold subscription fees, wire transfer fees, and paper statement fees may apply. Feb 16, 2024 · According to 11 analysts, the average rating for ITCI stock is "Strong Buy." The 12-month stock price forecast is $81.55, which is an increase of 16.23% from the latest price. .